CNBC Stock Blog
- Bulls Check In to Community Health
- Bank of America’s Worst-Case Scenario Gets More Real
- Mulling Buffett's Stock Advice? Get in With REITs: Fund Managers
- So Now You Can’t Give Microsoft Away?
- Groupon Needs More Disclosure: Analyst
- China’s Steelmakers Set for Turnaround: Analyst
- Bulls Bet Silicon Motion Will Bounce
- Tobacco Stocks a Hot Dividend Play: Analyst
ABOUT THE CNBC STOCK BLOG
RSS FEED
CNBC EXPLAINS
Election-Year Trades: Health Care
Text Size 
CNBC.com Writer
Two strategists, Stephen Wood at Russell Investments and John Manley at Citi Smith Barney, shared their market rebound strategies with CNBC.
“Health care is a good place to be,” said Manley. “Biotech [stocks] are cheap, and some of the big pharmaceutical companies have done nothing good for eight years. [Although] there’s a general fear that you don’t want to own any stocks before an election, when I see a consensus that rock-hard, I think there may be an opposite side to it.”
Wood, however, disagreed with Manley.
“I’m not as convinced with the election trade as a lot of people are,” he said. “I’m waiting for a lot of specifics from both candidates, but making big bets based on an election year may not be a good idea.”
Disclosures:
Disclosure information for Stephen Wood and John Manley were not immediately available.
_________________________________
Top biotech names:
Biogen Idec [BIIB
Loading...
()
]
Genentech [DNA
Loading...
()
]
Amgen [AMGN
Loading...
()
]
Genzyme [GENZ
Loading...
()
]
Celgene [CELG
Loading...
()
]
_________________________________
Data is a real-time snapshot *Data is delayed at least 15 minutes
